-
Signature
-
/s/ Yuki Whitmire, as Attorney-in-Fact
-
Issuer symbol
-
VST
-
Transactions as of
-
17 Jun 2025
-
Net transactions value
-
-$5,436,182
-
Form type
-
4
-
Filing time
-
18 Jun 2025, 21:29:52 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Moldovan Kristopher E. |
EVP and CFO |
6555 SIERRA DRIVE, IRVING |
/s/ Yuki Whitmire, as Attorney-in-Fact |
18 Jun 2025 |
0001940494 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
VST |
Common Stock |
Options Exercise |
$376,329 |
+14,169 |
+8.5% |
$26.56 |
181,323 |
17 Jun 2025 |
Direct |
F1 |
| transaction |
VST |
Common Stock |
Options Exercise |
$477,410 |
+20,775 |
+11% |
$22.98 |
202,098 |
17 Jun 2025 |
Direct |
F1 |
| transaction |
VST |
Common Stock |
Sale |
$6,289,920 |
-34,944 |
-17% |
$180.00 |
167,154 |
17 Jun 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
VST |
2019 Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-14,169 |
-100% |
$0.000000 |
0 |
17 Jun 2025 |
Common Stock |
14,169 |
$26.56 |
Direct |
F1, F2 |
| transaction |
VST |
2020 Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-20,775 |
-100% |
$0.000000 |
0 |
17 Jun 2025 |
Common Stock |
20,775 |
$22.98 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: